Leilani Paitoonpong

670 total citations
29 papers, 405 citations indexed

About

Leilani Paitoonpong is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Leilani Paitoonpong has authored 29 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 13 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Leilani Paitoonpong's work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (7 papers) and SARS-CoV-2 detection and testing (4 papers). Leilani Paitoonpong is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (7 papers) and SARS-CoV-2 detection and testing (4 papers). Leilani Paitoonpong collaborates with scholars based in Thailand, United States and Singapore. Leilani Paitoonpong's co-authors include Chusana Suankratay, Watsamon Jantarabenjakul, Opass Putcharoen, Gompol Suwanpimolkul, Jeerath Phannajit, Supaporn Wacharapluesadee, Leonel Mendoza, Ariya Chindamporn, Anawin Sanguankeo and Sikarin Upala and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Leilani Paitoonpong

29 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leilani Paitoonpong Thailand 11 228 140 67 60 36 29 405
Anna M. Acosta United States 12 132 0.6× 306 2.2× 104 1.6× 12 0.2× 20 0.6× 38 580
Abdoulreza Esteghamati Iran 14 219 1.0× 229 1.6× 114 1.7× 9 0.1× 10 0.3× 52 588
Caroline Atyeo United States 11 340 1.5× 139 1.0× 69 1.0× 6 0.1× 12 0.3× 20 611
S Dittmann Denmark 8 191 0.8× 173 1.2× 61 0.9× 96 1.6× 5 0.1× 20 457
Lize Cuypers Belgium 14 297 1.3× 296 2.1× 17 0.3× 5 0.1× 30 0.8× 59 556
Sigi Van den Wijngaert Belgium 12 428 1.9× 144 1.0× 9 0.1× 6 0.1× 40 1.1× 32 579
Marie-Josée Wendling France 10 336 1.5× 249 1.8× 40 0.6× 9 0.1× 26 0.7× 22 639
Barbara Montana United States 9 88 0.4× 190 1.4× 77 1.1× 8 0.1× 11 0.3× 16 298
Barbara Pahud United States 14 264 1.2× 292 2.1× 133 2.0× 5 0.1× 6 0.2× 36 616
Thomas G. Merrill United States 7 106 0.5× 78 0.6× 68 1.0× 26 0.4× 21 0.6× 14 355

Countries citing papers authored by Leilani Paitoonpong

Since Specialization
Citations

This map shows the geographic impact of Leilani Paitoonpong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leilani Paitoonpong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leilani Paitoonpong more than expected).

Fields of papers citing papers by Leilani Paitoonpong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leilani Paitoonpong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leilani Paitoonpong. The network helps show where Leilani Paitoonpong may publish in the future.

Co-authorship network of co-authors of Leilani Paitoonpong

This figure shows the co-authorship network connecting the top 25 collaborators of Leilani Paitoonpong. A scholar is included among the top collaborators of Leilani Paitoonpong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leilani Paitoonpong. Leilani Paitoonpong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wacharapluesadee, Supaporn, et al.. (2025). Multi-scale wastewater surveillance at a Bangkok tertiary care hospital: A potential sentinel site for real-time COVID-19 surveillance at hospital and national levels. PLOS Global Public Health. 5(4). e0004256–e0004256. 2 indexed citations
2.
Wacharapluesadee, Supaporn, Spencer L. Sterling, Kirana Noradechanon, et al.. (2024). Comparative Performance in the Detection of Four Coronavirus Genera from Human, Animal, and Environmental Specimens. Viruses. 16(4). 534–534. 2 indexed citations
3.
4.
Phannajit, Jeerath, et al.. (2022). Erectile dysfunction after COVID-19 recovery: A follow-up study. PLoS ONE. 17(10). e0276429–e0276429. 12 indexed citations
5.
Phannajit, Jeerath, Watsamon Jantarabenjakul, Leilani Paitoonpong, et al.. (2022). Benefits of Switching Mycophenolic Acid to Sirolimus on Serological Response after a SARS-CoV-2 Booster Dose among Kidney Transplant Recipients: A Pilot Study. Vaccines. 10(10). 1685–1685. 2 indexed citations
6.
Phannajit, Jeerath, Watsamon Jantarabenjakul, Leilani Paitoonpong, et al.. (2022). Comparison of the Immune Response After an Extended Primary Series of COVID-19 Vaccination in Kidney Transplant Recipients Receiving Standard Versus Mycophenolic Acid–sparing Immunosuppressive Regimen. Transplantation Direct. 8(11). e1393–e1393. 1 indexed citations
7.
8.
9.
Buathong, Rome, Sopon Iamsirithaworn, Supaporn Wacharapluesadee, et al.. (2021). Multiple clades of SARS‐CoV‐2 were introduced to Thailand during the first quarter of 2020. Microbiology and Immunology. 65(10). 405–409. 5 indexed citations
10.
Uaprasert, Noppacharn, et al.. (2021). Prevalence of thrombocytopenia, anti–platelet factor 4 antibodies and D‐dimer elevation in Thai people After ChAdOx1 nCoV‐19 vaccination. Research and Practice in Thrombosis and Haemostasis. 5(6). e12580–e12580. 13 indexed citations
11.
Uaprasert, Noppacharn, et al.. (2021). Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies. Research and Practice in Thrombosis and Haemostasis. 5(8). e12625–e12625. 3 indexed citations
12.
Putcharoen, Opass, Supaporn Wacharapluesadee, Wan Ni Chia, et al.. (2021). Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand. PLoS ONE. 16(2). e0246864–e0246864. 17 indexed citations
13.
Phannajit, Jeerath, et al.. (2021). COVID-19 vaccine acceptance, hesitancy, and determinants among physicians in a university-based teaching hospital in Thailand. BMC Infectious Diseases. 21(1). 1174–1174. 49 indexed citations
14.
Tungsanga, Somkanya, Pattama Torvorapanit, Suwasin Udomkarnjananun, et al.. (2020). A case of successful treatment of severe COVID‐19 pneumonia with favipiravir and tocilizumab in post–kidney transplant recipient. Transplant Infectious Disease. 23(1). e13388–e13388. 32 indexed citations
15.
Moonla, Chatphatai, Gompol Suwanpimolkul, Leilani Paitoonpong, et al.. (2020). Cold agglutinin disease following SARS‐CoV‐2 and Mycoplasma pneumoniae co‐infections. SHILAP Revista de lepidopterología. 8(12). 2402–2405. 9 indexed citations
16.
Wacharapluesadee, Supaporn, Thongchai Kaewpom, Weenassarin Ampoot, et al.. (2020). Evaluating the efficiency of specimen pooling for PCR‐based detection of COVID‐19. Journal of Medical Virology. 92(10). 2193–2199. 62 indexed citations
17.
Sriprasart, Thitiwat, et al.. (2019). Bilateral Adrenal Histoplasmosis. Balkan Medical Journal. 36(6). 359–360. 6 indexed citations
18.
Anugulruengkitt, Suvaporn, et al.. (2016). Prevalence and Characteristics of Pediatric Healthcare Workers without Immunity to Varicella zoster Virus. Japanese Journal of Infectious Diseases. 70(2). 216–218. 2 indexed citations
19.
Tantawichien, Terapong, et al.. (2015). Adult pertussis is unrecognized public health problem in Thailand. BMC Infectious Diseases. 16(1). 25–25. 28 indexed citations
20.
Paitoonpong, Leilani, et al.. (2008). Bartonella henselae: first reported isolate in a human in Thailand.. PubMed. 39(1). 123–9. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna M. Acosta Breakdown of academic impact, for papers by Abdoulreza Esteghamati Breakdown of academic impact, for papers by Caroline Atyeo Breakdown of academic impact, for papers by S Dittmann Breakdown of academic impact, for papers by Lize Cuypers Breakdown of academic impact, for papers by Sigi Van den Wijngaert Breakdown of academic impact, for papers by Marie-Josée Wendling Breakdown of academic impact, for papers by Barbara Montana Breakdown of academic impact, for papers by Barbara Pahud Breakdown of academic impact, for papers by Thomas G. Merrill
Rankless by CCL
2026